RENA THERAPEUTICS
In the pharmaceutical market, attention has been focused on nucleic acid drugs to meet unmet medical needs such as cancer and intractable diseases.This is because nucleic acid drugs have the following advantages.It is possible to target intracellular drug molecules that could not be targeted by conventional drugsDrug discovery research is possible for any gene as long as there is technology to deliver nucleic acids to the expression siteMore specific than low molecular weight compounds and less susceptible to side effects Unlike antibody drugs, nucleic acid drugs can be manufactured by chemical synthesis at a relatively low cost.
RENA THERAPEUTICS
Industry:
Biotechnology Clinical Trials Health Care Health Diagnostics Manufacturing Pharmaceutical
Founded:
2015-01-15
Address:
Tokyo, Tokyo, Japan
Country:
Japan
Website Url:
http://www.renatherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
03-4243-6081
Total Funding:
10.16 M USD
Technology used in webpage:
Viewport Meta SPF SSL By Default Google Font API Google Analytics LetsEncrypt WordPress Google Universal Analytics Font Awesome Wordpress Plugins
Similar Organizations
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Obsidian Therapeutics
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
Current Advisors List
Current Employees Featured
Founder
Investors List
KSP
KSP investment in Venture Round - Rena Therapeutics
Innovation Network Corporation of Japan
Innovation Network Corporation of Japan investment in Venture Round - Rena Therapeutics
Nippon Shokubai
Nippon Shokubai investment in Venture Round - Rena Therapeutics
Innovation Network Corporation of Japan
Innovation Network Corporation of Japan investment in Venture Round - Rena Therapeutics
Innovation Network Corporation of Japan
Innovation Network Corporation of Japan investment in Series A - Rena Therapeutics
KSP
KSP investment in Series A - Rena Therapeutics
DBJ Capital
DBJ Capital investment in Series A - Rena Therapeutics
Official Site Inspections
http://www.renatherapeutics.com
- Host name: 183.181.98.219
- IP address: 183.181.98.219
- Location: Osaka Japan
- Latitude: 34.6848
- Longitude: 135.5142
- Timezone: Asia/Tokyo
- Postal: 543-0062
